INOZYME PHARMA, INC. Depreciation
INOZYME PHARMA, INC. reported Depreciation of $742.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-03-10
- INOZYME PHARMA, INC. depreciation for fiscal 2024 was $742.00K, a 10.92% decline from fiscal 2023.
- INOZYME PHARMA, INC. depreciation for fiscal 2023 was $833.00K, a 11.96% increase from fiscal 2022.
- INOZYME PHARMA, INC. depreciation for fiscal 2022 was $744.00K, a 10.39% increase from fiscal 2021.
- INOZYME PHARMA, INC. depreciation for fiscal 2021 was $674.00K, a 210.60% increase from fiscal 2020.
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $742.00K 10-K · filed 2025-03-10 |
| 2023-12-31 | $833.00K 10-K · filed 2025-03-10 |
| 2022-12-31 | $744.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $674.00K 10-K · filed 2023-03-22 |
| 2020-12-31 | $217.00K 10-K · filed 2022-03-15 |